1.15 USD
↗ 0.01 (0.96%)PRE MARKET (AS OF 07:18 AM EDT)
Creative Medical Technology Holdings, Inc. Common Stock
CELZNASDAQ • USD
Market: OPEN
Creative Medical Technology Holdings, Inc. Common Stock (CELZ) is currently trading at $1.15. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place CELZ at a fair price relative to peers.
Technical & fundamental data as of Aug 28, 2026.
Open?$1.15
High?$1.15
Low?$1.11
Prev. Close?$1.14
Volume?7.7K
Avg. Volume?13.5M
VWAP?$1.12
Rel. Volume?0.00x
Bid / Ask
Bid?$0.99 × 100
Ask?$1.35 × 100
Spread?$0.36
Midpoint?$1.17
Valuation & Ratios
Market Cap?7.5M
Shares Out?6.6M
Float?3.7M
Float %?99.1%
P/E Ratio?N/A
P/B Ratio?0.87
EPS?-$0.92
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Employees
4
Market Cap
7.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2009-04-30
Address
211 E. OSBORN RD.
PHOENIX, AZ 85012
Phone: 480-399-2822
PHOENIX, AZ 85012
Phone: 480-399-2822
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?34
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.65Distress
Confidence?54%Low
Short InterestHigh
Short % of Float?15.97%High
Short Interest?584.6K
Days to Cover?1.0
Free Float3.7M
Avg Daily Volume38.5M
Settlement Date2026-08-14
Financial Health
Current Ratio?12.91Strong
Quick Ratio?12.73Strong
Cash Ratio?12.47Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?0.87CHEAP▾
Peers100
S&P97
P/S?2,505.17HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?0.2CHEAP▾
Peers100
S&P97
EV/Sales?-399.53CHEAP▾
S&P97
Returns & Efficiency
ROE?-69.8%WEAK▾
S&P3
ROA?-64.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-5901718
Enterprise Value?$-1198600
Fundamentals ratios updated end of day